Affichage 11 à 12 des 12 essais cliniques
1 | 2 |
1 |
2 |
1 | 2 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Randomized, Multicenter, Open-label, Phase III Study of Lurbinectedin Single-Agent or Lurbinectedin in Combination With Irinotecan Versus Investigator's Choice (Topotecan or Irinotecan) in Relapsed Small Cell Lung Cancer Patients
LAGOON NCT05153239  Actif en recrutement
|
CISSS DE LA MONTEREGIE-CENTRE HOPITAL CHARLES-LE MOYNE |
Marilyn Tessier 450-466-5000 poste 7691 |
|
|
(EN) A Randomized, Multicenter, Open-label, Phase III Study of Lurbinectedin Single-Agent or Lurbinectedin in Combination With Irinotecan Versus Investigator's Choice (Topotecan or Irinotecan) in Relapsed Small Cell Lung Cancer Patients
LAGOON NCT05153239 Actif en recrutement
|
HOPITAL DE LA CITE-DE-LA-SANTE |
Imane Benmouhoub 450-668-1010 poste 23671 |
Groupe d'étude en oncologie du Québec